Test Price
1,000 AED✅ Home Collection Available
Cytomegalovirus (CMV) Viral Load Quantitative Test in UAE | 1000 AED | 2026 DHA Guidelines
تحليل الحمض النووي للفيروس المضخم للخلايا (CMV) في الإمارات | 1000 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
-
▹
99.9% Diagnostic Sensitivity: Achieved via ISO 9001:2015 accredited processing utilizing Real-Time PCR (qPCR) and Whole Genome Sequencing (WGS) cross-validation.
حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة بتقنية PCR الكمي والتسلسل الجيني الكامل.
-
▹
Premium Logistics: Paid hospital-grade ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy service across UAE (8 AM - 11 PM).
خدمة سحب الدم المنزلي المتميزة بنظام النقل المبرد المعتمد طوال أيام الأسبوع.
-
▹
Clinical Guidance: Telephonic post-test clinical guidance by DHA-certified consultants to interpret your quantitative viral load results.
إرشاد طبي عبر الهاتف بعد الفحص لتفسير نتائج الحمل الفيروسي الكمي.
-
▹
Insurance & Billing: Direct insurance billing verification via WhatsApp at +971 54 548 8731.
Comprehensive Overview
The Cytomegalovirus (CMV) Viral Load Quantitative Test precisely measures the amount of CMV DNA present in the blood or tissue, essential for monitoring active infection versus latent stages. Utilizing state-of-the-art Real-Time PCR (qPCR) combined with Whole Genome Sequencing (WGS) cross-validation, this test delivers unparalleled accuracy for transplant recipients, immunocompromised patients, and those undergoing antiviral therapy, strictly adhering to the 2026 UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on communicable disease reporting.
| Feature | Our Test (qPCR + WGS) | Standard Alternative (ELISA/Serology) |
|---|---|---|
| Target Detection | CMV DNA (Viral Load) | CMV IgG/IgM Antibodies |
| Diagnostic Precision | >99.9% Sensitivity | ~85-90% Sensitivity (Window Period) |
| Report Turnaround | 24 Hours (Urgent) / 36 Hours (Email) | 2-5 Working Days |
| Clinical Utility | Monitoring active infection & therapy | Past exposure screening only |
Physician Insight & Safety Protocol
“As a clinical consultant, I emphasize that an undetectable CMV viral load does not necessarily rule out latent infection, particularly in seropositive individuals. This quantitative test is most valuable when serial measurements are compared; a rising viral load—even within the normal range—demands immediate clinical correlation to prevent end-organ disease, especially in solid organ or stem cell transplant recipients.”
— Dr. PRABHAKAR REDDY, DHA License No: 61713011
Do not discontinue any prescribed immunosuppressants, antivirals (e.g., Ganciclovir, Valganciclovir), or corticosteroids without explicit consultation with your transplant team or infectious disease specialist. Abrupt modification of medication can lead to viral rebound and acute graft rejection.
🚨 Patient Safety & Exclusion Criteria
Exclusion Criteria for Home Collection: Patients currently requiring supplemental oxygen, those with uncontrolled coagulopathy, or hemodynamic instability require hospital-based phlebotomy.
Emergency Red Flags: If you experience sudden vision loss (retinitis), severe abdominal pain (colitis), or acute confusion (encephalitis), do not wait for test results. Proceed directly to the nearest Emergency Department. These conditions represent potential CMV end-organ disease requiring immediate intervention.
Patient FAQ & Clinical Guidance
The critical distinction lies in diagnosing active replication versus dormant exposure; the CMV IgG test only confirms past contact with the virus, while our Quantitative PCR test directly measures the current viral burden in your bloodstream.
Physicians, particularly general practitioners and infectious disease specialists, rely on the viral load test to guide preemptive therapy in transplant recipients and monitor response to antivirals, as 2026 DHA guidelines now mandate quantitative reporting for high-risk cohorts.
ما الفرق بين اختبار الأجسام المضادة CMV IgG وفحص الحمل الفيروسي الكمي؟
الفرق الجوهري هو أن فحص الأجسام المضادة يثبت الإصابة السابقة فقط، بينما يقيس فحص الحمض النووي الكمي الحمل الفيروسي النشط في الدم بدقة لتوجيه العلاج الفوري.
Our premium service delivers urgent quantitative PCR results via phone within 24 hours to facilitate immediate clinical decision-making for acute care scenarios.
For standard monitoring, the hardcopy report arrives on the 3rd working day, while the softcopy is securely emailed within 36 hours. We strictly adhere to UAE PDPL (Data Privacy) laws, ensuring your results are encrypted and accessible only to the authorized physician and patient.
ما مدة ظهور نتيجة فحص الحمل الفيروسي للفيروس المضخم للخلايا؟
نقدم خدمة النتائج العاجلة خلال 24 ساعة هاتفياً للحالات الحرجة، بينما تصل النتائج الرسمية الورقية في يوم العمل الثالث مع الالتزام بقوانين خصوصية البيانات الإماراتية.
Our VIP mobile phlebotomy team strictly follows ISO 9001:2015 cold-chain logistics and the CDS Law 2026 protocols for minor consent and safety.
We enforce stringent verification of Emirates ID and signed consent forms before any sample collection. Our DHA-MOHAP Standard Nomenclature labeling ensures zero pre-analytical errors from home to the integrated lab facility, making the process safer than walk-in clinics for immunocompromised patients.
هل خدمة السحب المنزلي آمنة ومتوافقة مع القوانين الصحية في الإمارات؟
فريقنا المتنقل يلتزم بمعايير الآيزو 9001:2015 وقانون الأمراض السارية 2026، مع ضمان التوثيق الكامل للهوية والموافقة المستنيرة لضمان أعلى معايير السلامة للمرضى.
ISO 9001:2015 Certified | Cert: INT/EGQ/2509DA/3139 | Licensed by DHA | Federal Decree-Law No. 41 of 2024 (Art. 87) & UAE PDPL Compliance
For immediate booking or insurance verification, contact +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians